More than 50 years of landmark results
Since 1967, Lowey Dannenberg has represented investors and major corporations in complex litigation, recovering billions of dollars on their behalf.Solutions for Complex Cases
Professional Recommendations
Recent Cases
Xerox
Notable
Lowey Dannenberg served as class counsel, successfully challenging a multi-billion-dollar merger between Xerox Corp. and Affiliated Computer Systems (“ACS”), which overcompensated ACS’ former Chairman Darwin Deason at the expense of […]
Community Health Systems
Notable
Lowey served as lead counsel representing the New York City Pension Funds and the certified class of investors against one of the nation’s largest hospital systems, Community Health Systems (“CHS”).
Generic Pharmaceuticals Price Fixing
Antitrust, Health Care, Healthcare
Lowey Dannenberg represents 34 of the nation’s largest health insurers, including Elevance Health (formerly known as Anthem), Aetna, Humana, and 25 BlueCross BlueShield licensees in connection with their claims relating […]
News
Lowey Dannenberg and Co-Counsel File Class Action on Behalf of End-Payors for Immunosuppressive Drug Stelara (Ustekinumab)
On December 7, 2023, Lowey Dannenberg, P.C. and its co-counsel, representing named Plaintiff CareFirst BlueCross BlueShield,filed suit against Stelara manufacturer Johnson & Johnson (“J&J”) in the U.S. District Court for the Eastern District of Virginia. The…
Blog
SEC Investigations, Climate Risk Disclosures & Impact on Corporate Governance
On Monday, March 21, 2021, the Securities Exchange Commission released a 510-page proposal that would require U.S.-listed companies to provide certain climate-related information in their registration statements and annual reports. This long-anticipated draft rule coupled with increased investor...

